BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2015
View Archived Issues
SKY92 gene expression signature combined with ISS in MM survival prognosis
Read More
Transient expression of ZSCAN4 corrects trisomy in cells from people with Down syndrome
Read More
Homozygous mutation in PPP1R15B leads to beta-cell dysfunction and diabetes
Read More
New financing round at Pharmalink to fund development of phase III program for Nefecon
Read More
Nivolumab shows enhanced overall survival in mRCC patients
Read More
Genzyme opts into Alnylam Pharmaceuticals' ALN-AT3 hemophilia program
Read More
BioCancell advances combination of BC-819 and BCG for bladder cancer
Read More
Cellectar Biosciences awarded grant to advance phospholipid drug conjugate platform
Read More
REV-002 reduces joint pain in phase IIa trial in acute gout arthritis
Read More
DeuteRx completes financing to fund clinical trials of DRX-065 for adrenoleukodystrophy
Read More
Arvinas enters license agreement with Genentech to develop therapeutics based on PROTAC technology
Read More
Celdara and Pulmatrix receive NIH grant to develop inhaled biologic for IPF
Read More
Photocure initiates phase III study of Cysview with blue light cystoscopy in surveillance setting
Read More
New approaches for the treatment of diabetes: ECM capsules and bioactive nanocoatings
Read More
Novel mitochondrial RNA mutation linked to breast cancer
Read More
IAPs show promise for the treatment of M. tuberculosis and M. avium infections
Read More
Anthera begins phase III SOLUTION study of oral Sollpura
Read More
Encore Vision starts phase I/II trial of EV-06 in presbyopia
Read More
Algiax discloses GABA(A) receptor modulators
Read More
Bristol-Myers Squibb introduces NS5B inhibitors
Read More
Yissum reports mushroom ostreolyisin compositions
Read More
Nivalis Therapeutics divulges CFTR modulators
Read More
AstraZeneca introduces ENaC modulators
Read More
Innate Pharma initiates phase I/II trial of IPH-2201 in combination with ibrutinib for CLL
Read More
FDA approves Aristada for schizophrenia
Read More
Cardinal Health completes acquisition of J&J's Cordis business
Read More
Cobimetinib increases overall survival in patients with melanoma treated with vemurafenib
Read More
Gilead's new treatment combination of Letairis and tadalafil gains FDA approval for PAH
Read More
Cell Therapy plans European CMA submission for Heartcel
Read More